9.9056
price down icon3.69%   -0.1144
 
loading

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
27.16%
-7.966
-10.94 -13.92 -10.55 -9.582
Nonoperating Income/Loss
26.32%
0.096
0.076 0.105 -0.005 0.012
Income/Loss From Continuing Operations Before Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Net Income/Loss
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Diluted Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Basic Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Diluted Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.41
price down icon 0.51%
$28.83
price up icon 0.42%
$100.47
price down icon 1.20%
$103.85
price down icon 0.08%
biotechnology ONC
$310.01
price down icon 0.52%
$184.61
price down icon 0.50%
Kapitalisierung:     |  Volumen (24h):